Cargando…

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma

Hypoxia is a common feature of many solid tumors, including hepatocellular carcinoma (HCC). Hypoxia can promote tumor progression and induce radiation and chemotherapy resistance. As one of the major mediators of hypoxic response, hypoxia inducible factor-1 (HIF-1) has been shown to activate hypoxia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Dongjun, Wang, Zhongxia, Wu, Junyi, Jiang, Chunping, Wu, Junhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101982/ https://www.ncbi.nlm.nih.gov/pubmed/25101278 http://dx.doi.org/10.1155/2014/409272

Ejemplares similares

Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro
por: Qu, Zhen, et al.
Publicado: (2016)

Baicalein Induces Apoptosis and Autophagy via Endoplasmic Reticulum Stress in Hepatocellular Carcinoma Cells
por: Wang, Zhongxia, et al.
Publicado: (2014)

PRRX1 deficiency induces mesenchymal‐epithelial transition through PITX2/miR‐200–dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma
por: Chen, Weibo, et al.
Publicado: (2021)

Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma
por: Zhang, Guang, et al.
Publicado: (2013)

Associations of miR-499 and miR-34b/c Polymorphisms with Susceptibility to Hepatocellular Carcinoma: An Evidence-Based Evaluation
por: Wang, Zhongxia, et al.
Publicado: (2013)

UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
por: Wu, Junyi, et al.
Publicado: (2023)

Lack of Association of Two Common Polymorphisms rs2910164 and rs11614913 with Susceptibility to Hepatocellular Carcinoma: A Meta-Analysis
por: Wang, Zhongxia, et al.
Publicado: (2012)

Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
por: Shi, Weiwei, et al.
Publicado: (2020)

Hypoxia inducible factors in hepatocellular carcinoma
por: Chen, Chu, et al.
Publicado: (2017)

Hypoxia-inducible factors in hepatocellular carcinoma
por: Guo, Yang, et al.
Publicado: (2020)

Dehydroabietic Acid Derivative QC2 Induces Oncosis in Hepatocellular Carcinoma Cells
por: Zhang, Guang, et al.
Publicado: (2014)

Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis
por: Qu, Zhen, et al.
Publicado: (2017)

CFDP1 promotes hepatocellular carcinoma progression through activating NEDD4/PTEN/PI3K/AKT signaling pathway
por: Zhou, Yan, et al.
Publicado: (2022)

Long noncoding RNA SNHG4 promotes the malignant progression of hepatocellular carcinoma through the miR‐211‐5p/CREB5 axis
por: Qiu, Jiannan, et al.
Publicado: (2022)

Hypoxia signaling in cancer: Implications for therapeutic interventions
por: Zhuang, Yan, et al.
Publicado: (2023)

Dehydroabietic Acid Derivative QC4 Induces Gastric Cancer Cell Death via Oncosis and Apoptosis
por: Luo, Dongjun, et al.
Publicado: (2016)

Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma
por: Huynh, Kenneth N., et al.
Publicado: (2023)

IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling
por: Hu, Wei, et al.
Publicado: (2019)

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
por: Kim, Jin-Wook
Publicado: (2010)

Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
por: Xiao, Chunying, et al.
Publicado: (2023)

Expression of caspase-3 and hypoxia inducible factor 1α in hepatocellular carcinoma complicated by hemorrhage and necrosis
por: Liang, Hui, et al.
Publicado: (2021)

Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma
por: Chen, Huan, et al.
Publicado: (2022)

Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma
por: Zhang, Lin, et al.
Publicado: (2013)

Upregulation of Nogo‐B by hypoxia inducible factor‐1 and activator protein‐1 in hepatocellular carcinoma
por: Han, Dingding, et al.
Publicado: (2021)

Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
por: Zeng, Zhi, et al.
Publicado: (2021)

Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Li, Shanshan, et al.
Publicado: (2011)

Hepatic Stellate Cell Coculture Enables Sorafenib Resistance in Huh7 Cells through HGF/c-Met/Akt and Jak2/Stat3 Pathways
por: Chen, Weibo, et al.
Publicado: (2014)

DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway
por: Zhang, Shan, et al.
Publicado: (2020)

SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway
por: Shi, Weiwei, et al.
Publicado: (2021)

Hypoxia-Inducible Factor in Thyroid Carcinoma
por: Burrows, Natalie, et al.
Publicado: (2011)

Novel Molecular Targets in Malignant Diseases of Digestive System 2014
por: Jiang, Chunping, et al.
Publicado: (2015)

PP2A-Mediated Anticancer Therapy
por: Chen, Weibo, et al.
Publicado: (2013)

The role of SOCS proteins in the development of virus- induced hepatocellular carcinoma
por: Xie, Jinyan, et al.
Publicado: (2021)

Role of hypoxia inducible factor-1 in cancer stem cells
por: Zhang, Qi, et al.
Publicado: (2021)

The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease
por: Liu, Huixia, et al.
Publicado: (2022)

Liraglutide activates nature killer cell-mediated antitumor responses by inhibiting IL-6/STAT3 signaling in hepatocellular carcinoma
por: Lu, Xian, et al.
Publicado: (2020)

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma
por: Liu, L-p, et al.
Publicado: (2014)

Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy
por: Ma, Cheng, et al.
Publicado: (2023)

A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
por: Zhang, Dengke, et al.
Publicado: (2022)

CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma
por: Zhang, Xiaoling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3grrc50d6p3go91n3es0n9e3if